Calcila (200 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Pharmasynth Formulation Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Vit B12, Dibasic Calcium Phosphate,L-Lysine,Vit D3. This drug comes in the form of Syrup. The general packing available for this medicine consists of 200 ml and is priced at Rs 60 (arround $0.84 US Dollar)
The main active ingredients or salts in Calcila (200 ml) are :
Vit D3-200 iu
Dibasic Calcium Phosphate-450 mg
Vit B12-2.5 mcg
L-Lysine-50 mg
Vit B12 Indication (Prescribed for or used as): Vitamin B12 deficiency. Neuropathies, psychiatrics disorders, cutaneous sarcoid. Tobacco amblyopia - hydroxocobalamin is of some benefit.
For more details on Vit B12, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Vit B12..
Dibasic Calcium Phosphate Indication (Prescribed for or used as):
For more details on Dibasic Calcium Phosphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dibasic Calcium Phosphate..
L-Lysine Indication (Prescribed for or used as):
For more details on L-Lysine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : L-Lysine..
Vit D3 Indication (Prescribed for or used as): Vitamin D deficiency
For more details on Vit D3, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Vit D3..
Calcila (200 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 1 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Calcila (200 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Vit D3-200 iu Dibasic Calcium Phosphate-450 mg Vit B12-2.5 mcg L-Lysine-50 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.